Full-Time
Develops advanced biotech and high-tech products
No salary listed
Senior, Expert
No H1B Sponsorship
North Carolina, USA
US Citizenship Required
Get referrals →
You have ways to get a Science referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 8 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Science.xyz develops specialized products and services in the biotech and high-tech sectors, focusing on areas like synthetic biology, stem cell research, microfabrication, and semiconductor devices. Their products are designed to meet the needs of clients such as academic institutions, research labs, and biotech companies. The company employs a skilled team of professionals, including scientists and engineers, to ensure their offerings are advanced and effective. Unlike many competitors, Science.xyz emphasizes collaboration and partnerships within the scientific community to enhance their product development. The goal of Science.xyz is to leverage scientific research to create valuable solutions that contribute to advancements in technology and biotechnology.
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$126M
Headquarters
Alameda, California
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Flexible Vacation
Paid Parental Leave
Paid Sick Leave
401(k) Retirement Plan
Dependent Care Flexible Spending Account
Flexible Spending Account
Science Corp, a neurotech firm founded by Neuralink co-founder Max Hodak, has raised over $100 million in funding led by Khosla Ventures. This adds to the $186 million previously raised. The funding will accelerate the development and commercialization of their brain-computer interface technologies, including the PRIMA retinal implant system for vision restoration in advanced AMD patients. The system uses a wireless implant and specialized glasses to help patients perceive visual forms.
New funding follows impressive vision restoration results in advanced AMD patients using retinal implant system.
Science Corp., a technology company focused on the human brain started by Neuralink Corp. co-founder Max Hodak, has raised over $100 million in a funding round led by Khosla Ventures.
Science Corporation, a U.S. BCI company, is developing a method that secures more communication channels using neurons instead of inserting metal electrodes into the brain, while minimizing brain damage.
At Science, Science Corp. is developing a biohybrid probe technology using highly engineered, stem cell-derived neurons embedded in vitro in electronics and engrafted into the brain, forming new biological connections.